OpenAI, Moderna expand AI use in drug development

Tech in Asiaen

OpenAI, Moderna expand AI use in drug development

Before ChatGPT Enterprise, Moderna built an internal tool, mChat, using OpenAI's API.

This is a short summary published by AI Global Wire. The full article is owned and hosted by Tech in Asia — open it there to read it in full.

Read the full story at Tech in Asia
  • OpenAI
  • Verktyg

Related AI news